Integer Holdings (ITGR) Income from Continuing Operations (2010 - 2026)
Integer Holdings (ITGR) reported Income from Continuing Operations of 16506000.0 for Q2 2026, up 173.47% on a YoY basis from 6035667.85 in Q2 2025, and down 66.04% sequentially from 48608000.0 in Q4 2025.
Integer Holdings (ITGR) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Income from Continuing Operations data on file, last reported at 16506000.0 in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations rose 173.47% year-over-year to 16506000.0; the trailing twelve-month figure through Apr 2026 stood at 141801000.0 (up 81.8% YoY), and the FY2025 full-year result was 102830000.0, down 15.05% from the prior year.
- Income from Continuing Operations retreated to 16506000.0 in Q2 2026, from 48608000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 48608000.0 in Q4 2025 to a low of 22465000.0 in Q1 2025.
- A 5-year average of 23063647.06 and a median of 23971000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations slumped 209.1% in 2025 and soared 173.47% in 2026, its largest moves.
- Tracing ITGR's Income from Continuing Operations over 5 years: stood at 11453000.0 in 2022, then surged by 134.11% to 26813000.0 in 2023, then advanced by 22.97% to 32973000.0 in 2024, then surged by 47.42% to 48608000.0 in 2025, then tumbled by 66.04% to 16506000.0 in 2026.
- Business Quant data shows ITGR's Income from Continuing Operations at 16506000.0 in Q2 2026, 48608000.0 in Q4 2025, and 39678000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | 16.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 16.51 Mn |
| Dec 31, 2025 | 48.61 Mn |
| Sep 26, 2025 | 39.68 Mn |
| Jun 27, 2025 | 37.01 Mn |
| Mar 28, 2025 | -22.47 Mn |
| Dec 31, 2024 | 32.97 Mn |
| Sep 27, 2024 | 36.28 Mn |
| Jun 28, 2024 | 31.21 Mn |
| Mar 29, 2024 | 20.59 Mn |
| Dec 31, 2023 | 26.81 Mn |
| Sep 29, 2023 | 28.17 Mn |
| Jun 30, 2023 | 23.97 Mn |
| Mar 31, 2023 | 13.07 Mn |
| Dec 31, 2022 | 11.45 Mn |
| Sep 30, 2022 | 16.06 Mn |
| Jul 1, 2022 | 20.84 Mn |
| Apr 1, 2022 | 11.32 Mn |
| Dec 31, 2021 | 20.04 Mn |
| Oct 1, 2021 | 22.09 Mn |
| Jul 2, 2021 | 29.43 Mn |